Recombinant multi-species NFAT5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NFAT5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The product of this gene is a member of the nuclear factors of activated T cells family of transcription factors. Proteins belonging to this family play a central role in inducible gene transcription during the immune response. This protein regulates gene expression induced by osmotic stress in mammalian cells. Unlike monomeric members of this protein family, this protein exists as a homodimer and forms stable dimers with DNA elements. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: B130038B15Rik,CAG-8,CAG80,NF-AT5,NFAT5,NFATL1,NFATZ,Nfat,Nfat5,Nuclear factor of activated T-cells 5,OREBP,T-cell transcription factor NFAT5,TONEBP,TonEBP,TonEBP),Tonicity-responsive enhancer-binding protein (TonE-binding protein,mKIAA0827,nfatz

Target products collectionGo to NFAT5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3722-Ag-1/ GM-Tg-hg-IP3722-Ag-2 Human NFAT5 protein Human
GM-Tg-rg-IP3722-Ag-1/ GM-Tg-rg-IP3722-Ag-2 Rat NFAT5 protein Rat
GM-Tg-mg-IP3722-Ag-1/ GM-Tg-mg-IP3722-Ag-2 Mouse NFAT5 protein Mouse
GM-Tg-cynog-IP3722-Ag-1/ GM-Tg-cynog-IP3722-Ag-2 Cynomolgus/Rhesus macaque NFAT5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3722-Ag-1/ GM-Tg-felg-IP3722-Ag-2 Feline NFAT5 protein Feline
GM-Tg-cang-IP3722-Ag-1/ GM-Tg-cang-IP3722-Ag-2 Canine NFAT5 protein Canine
GM-Tg-bovg-IP3722-Ag-1/ GM-Tg-bovg-IP3722-Ag-2 Bovine NFAT5 protein Bovine
GM-Tg-equg-IP3722-Ag-1/ GM-Tg-equg-IP3722-Ag-2 Equine NFAT5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3722-Ag-1/ GM-Tg-hg-IP3722-Ag-2; GM-Tg-rg-IP3722-Ag-1/ GM-Tg-rg-IP3722-Ag-2;
GM-Tg-mg-IP3722-Ag-1/ GM-Tg-mg-IP3722-Ag-2; GM-Tg-cynog-IP3722-Ag-1/ GM-Tg-cynog-IP3722-Ag-2;
GM-Tg-felg-IP3722-Ag-1/ GM-Tg-felg-IP3722-Ag-2; GM-Tg-cang-IP3722-Ag-1/ GM-Tg-cang-IP3722-Ag-2;
GM-Tg-bovg-IP3722-Ag-1/ GM-Tg-bovg-IP3722-Ag-2; GM-Tg-equg-IP3722-Ag-1/ GM-Tg-equg-IP3722-Ag-2
Products Name NFAT5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NFAT5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NFAT5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.